ziftomenib
kura oncology
['komet-001', 'ziftomenib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', 'myeloid', 'kura ']
today at the annual meeting, we present updated clinical data from komet-001, a phase 1/2 trial of menin inhibitor #ziftomenib for patients with relapsed/refractory acute myeloid leukemia (aml). view the full announcement here: #ash22 
We're working to realize the promise of precision medicines. Our goal is to help patients with cancer lead longer, better lives.